Evidence map›Paper›PMID 30728823›Full record

ArticleFrontiers in immunology2018

Germinal Center Alloantibody Responses Mediate Progression of Chronic Allograft Injury.

Manu Chhabra, Jawaher Alsughayyir, M Saeed Qureshi, Mekhola Mallik, Jason M Ali, Ivonne Gamper, Ellen L Moseley, Sarah Peacock, Vasilis Kosmoliaptsis, Martin J Goddard and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Activation and Regulation of Indirect Alloresponses in Transplanted Patients With Donor Specific Antibodies and Chronic Rejection.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Review
  3. Allorecognition Unveiled: Integrating Recent Breakthroughs Into the Current Paradigm.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Follicular T cells mediate donor-specific antibody and rejection after solid organ transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  11. Review
  12. Article
  13. Superior inhibition of alloantibody responses with selective CD28 blockade is CTLA-4 dependent and T follicular helper cell specific.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  14. Therapies for Chronic Allograft Rejection.Frontiers in pharmacology · 2021
    Review
  15. Article
  16. Review
  17. Review
  18. Prolongation of allograft survival by passenger donor regulatory T cells.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Manu ChhabraSchool of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
Jawaher AlsughayyirSchool of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
M Saeed QureshiSchool of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
Mekhola MallikSchool of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
Jason M AliSchool of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
Ivonne GamperSchool of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
Ellen L MoseleyDepartment of Pathology, Papworth Hospital, Papworth Everard, United Kingdom.
Sarah PeacockHistocompatibility and Immunogenetics Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Vasilis KosmoliaptsisSchool of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
Martin J GoddardDepartment of Pathology, Papworth Hospital, Papworth Everard, United Kingdom.
Michelle A LintermanLaboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.
Reza MotallebzadehDivision of Surgery and Interventional Science, University College London, London, United Kingdom.
Gavin J PettigrewSchool of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
University of Cambridge · GBPapworth Hospital · GBBabraham Institute · GBCambridge University Hospitals NHS Foundation Trust · GBUniversity College London · GB

Funding

British Heart Foundation FS/12/87/29899British Heart Foundation PG/10/002/28143Department of Health PDF-2016-09-065Wellcome Trust
6 · The paper itself

Abstract

Different profiles of alloantibody responses are observed in the clinic, with those that persist, often despite targeted treatment, associated with poorer long-term transplant outcomes. Although such responses would suggest an underlying germinal center (GC) response, the relationship to cellular events within the allospecific B cell population is unclear. Here we examine the contribution of germinal center (GC) humoral alloimmunity to chronic antibody mediated rejection (AMR). A murine model of chronic AMR was developed in which T cell deficient (

Indexed as

Immunity, HumoralAllograftsAnimalsChronic DiseaseDisease Models, AnimalDisease ProgressionGerminal CenterGraft RejectionHeart TransplantationHumansIsoantibodiesIsoantigensMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutIsoantibodiesIsoantigensReceptors, Antigen, T-Cell, alpha-betaSh2d1a protein, mouseSignaling Lymphocytic Activation Molecule Associated Proteinallograftextrafollicular B cell responsegerminal center (GC)humoral allograft rejectiontransplantation

Identifiers

PMID30728823
PMCPMC6351502
OpenAlexW2913418621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.